FDA Adverse Event Other Summary report: N

ADVIA CENTAUR HBSAG ASSAY

MDR report key: 1616627 · Received February 22, 2010

Report

Report Number
1219913-2010-00025
Event Type
Other
Date Received
February 22, 2010
Date of Event
February 12, 2010
Report Date
February 15, 2010
Manufacturer
SIEMENS HEALTHCARE DIAGNOSTICS, INC.
Product Code
LOM
PMA / PMN Number
P030029
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
NJ, US
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 1

THE CAUSE FOR THE DISCORDANT (B)(6) RESULT WITH THE ALTERNATE METHOD IS UNK. THE INSTRUMENT IS PERFORMING WITHIN SPECIFICATIONS. NO FURTHER EVAL OF THE DEVICE IS REQUIRED.

Additional Manufacturer Narrative · 1

ADDITIONAL INFORMATION: THE CUSTOMER SENT THE PATIENT SAMPLE TO SIEMENS HEALTHCARE DIAGNOSTICS FOR FURTHER TESTING. THE PATIENT SAMPLE WAS TESTED ON THE ADVIA CENTAUR HBSAG AND THE RESULT WAS POSITIVE. THE SAMPLE IS NEUTRALIZED AT 95.8% WITH THE CONFIRMATORY ASSAY. THE CONCLUSION IS, THERE IS HBSAG IN THE RETURNED SPECIMEN. THIS IS CONCORDANT WITH THE CUSTOMER FINDINGS.

Description of Event or Problem · 1

A POSITIVE ADVIA CENTAUR (B)(6) RESULT WAS OBTAINED FOR A PT SAMPLE AND CONFIRMED USING THE ADVIA CENTAUR CONFIRMATORY ASSAY. THE PT SAMPLE WAS RUN ON FOUR DIFFERENT ADVIA CENTAURS WITH THE SAME RESULT EVERY TIME. THE CUSTOMER TESTED THE PT SAMPLE ON AN ALTERNATE METHOD AND THE RESULT WAS NEGATIVE FOR (B)(6) . PT TREATMENT WAS NOT PRESCRIBED OR ALTERED. THERE WAS NO REPORT OF ADVERSE HEALTH CONSEQUENCES DUE TO THE DISCORDANT (B)(6) RESULTS.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 ADVIA CENTAUR HBSAG ASSAY HBS IMMUNOASSAY LOM SIEMENS HEALTHCARE DIAGNOSTICS, INC. NA 145

Patients

Seq Age Sex Outcome Treatment
1